Bionano Genomics, Inc. (BNGO) has a consensus analyst rating of Buy, based on 7 analysts covering the stock. Of those, 4 recommend buying, 3 recommend holding, and 0 recommend selling.
The analyst consensus price target for BNGO is $46.50, representing a +3,743.0% upside from the current price of $1.21. Price targets range from a low of $1.00 to a high of $175.00.
